S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
MNKD · MannKind Corporation
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$3.05
-0.05
(-1.45%)
● At close: October 21 at 4:00:00 PM EDT
$3.08
+0.03
(+0.98%)
Overnight:
8:06:35 PM EDT
DAY'S RANGE
$3.05
$3.04
$3.12
52-WEEK RANGE
$3.05
$2.23
$6.51
What's happening
- MNKD is down 1.45% today, trading at $3.05. — Live quote
- Volume today (102,341) is well below its 3-month average of 4,659,490. (Finnhub fundamentals)
- Reports earnings on 2026-11-10 (after market close), 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.06 actual vs. $-0.00 estimated (-3900.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 8
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (14 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
MNKD
-45.33%
vs S&P 500
-58.10%
1-YEAR RETURN
MNKD
-43.53%
vs S&P 500
-58.09%
6-MONTH RETURN
MNKD
+12.73%
3-MONTH RETURN
MNKD
-23.46%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.06
Est. $-0.00
MISS -3900.0%
2026-04-26 (Q1 2026)
$-0.05
Est. $-0.00
MISS -3233.3%
2026-01-26 (Q4 2025)
$-0.05
Est. $0.01
MISS -440.1%
2025-10-26 (Q3 2025)
$0.07
Est. $0.02
BEAT +205.9%
Valuation Measures & Ratios
Enterprise Value4$1.52B
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)2.54
Price / Book788.13
EV4 / Revenue3.86
EV4 / EBITDA63.60
Profit Margin-10.87%
Operating Margin2.31%
Return on Equity (ROE8)-297.71%
Return on Assets (ROA9)-6.19%
Avg Volume (3M)4,659,490
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.36B | $817.7M | $1.43B | — | $1.66B |
| P/E | -50.29 | 157.48 | 42.84 | — | 49.80 |
| Price/Sales | 3.79 | 2.50 | 4.65 | — | 5.78 |
| Price/Book | -20.20 | -13.81 | -32.08 | — | -28.31 |
| EV/Revenue | 4.53 | 3.31 | 4.60 | — | 5.74 |
| ROE | 40.18% | -8.77% | -74.88% | — | -56.85% |
| ROA | -3.69% | 0.70% | 6.74% | — | 8.13% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short26,157,578
Change from Prior Settlement-11.02%
% of Float—
Days to Cover (Short Ratio)4.44
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 42.9% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-09-28; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -10.9%. Finnhub fundamentals ↗
- Trailing 52-week price return is -43.5%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on MNKD
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $109.4M | $90.2M | $82.1M | $76.5M | $78.4M | $70.1M | $72.4M | $66.3M |
| Operating income | -$350.0K | -$1.7M | $18.9M | $5.3M | $22.3M | $12.8M | $16.6M | $16.7M |
| Net income | -$19.0M | -$16.6M | $8.0M | $668.0K | $13.2M | $11.6M | -$2.0M | $10.6M |
| EPS (diluted) | $-0.06 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.04 | $-0.01 | $0.04 |
| EPS (basic) | $-0.06 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.04 | $-0.01 | $0.04 |
| Operating margin | -$0 | -$2 | $23 | $7 | $28 | $18 | $23 | $25 |
| Net margin | -$17 | -$18 | $10 | $1 | $17 | $16 | -$3 | $16 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $732.3M | $744.4M | $792.2M | $494.6M | $411.7M | $410.1M | $393.8M | $464.2M |
| Total liabilities | $799.5M | $803.6M | $843.2M | $539.2M | $466.7M | $468.8M | $472.7M | $674.1M |
| Stockholders' equity | -$67.2M | -$59.2M | -$51.0M | -$44.6M | -$55.0M | -$58.6M | -$78.8M | -$209.9M |
| Total current assets | $245.7M | $251.2M | $291.6M | $358.8M | $279.0M | $273.7M | $268.3M | $327.7M |
| Total current liabilities | $142.9M | $134.6M | $171.0M | $109.1M | $111.8M | $115.9M | $81.8M | $72.1M |
| Cash & equivalents | $52.9M | $52.8M | $74.9M | $127.4M | $57.0M | $47.3M | $46.3M | $62.4M |
| Marketable securities (current) | $58.2M | $81.0M | $96.5M | $132.6M | $122.0M | $134.2M | $150.9M | $189.2M |
| Accounts receivable | $43.2M | $28.1M | $38.4M | $17.4M | $27.1M | $28.9M | $11.8M | $18.2M |
| Inventory | $44.4M | $49.2M | $35.3M | $27.0M | $28.5M | $28.9M | $27.9M | $26.7M |
| Marketable securities (non-current) | — | — | $5.0M | $26.2M | $22.2M | $16.7M | $5.5M | $16.8M |
| Property, plant & equipment | $85.2M | $82.6M | $82.4M | $82.7M | $83.0M | $83.8M | $85.4M | $85.3M |
| Goodwill | $67.6M | $67.6M | $67.6M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M |
| Intangible assets | $5.0M | $5.0M | $5.1M | $5.1M | $5.2M | $5.2M | $5.3M | $5.3M |
| Other non-current assets | $17.1M | $22.0M | $20.1M | $19.1M | $19.6M | $28.1M | $26.8M | $26.4M |
| Accounts payable | $11.0M | $16.1M | $9.0M | $7.3M | $10.3M | $5.0M | $6.8M | $6.4M |
| Accrued liabilities | $60.8M | $58.6M | $64.6M | $31.4M | $30.9M | $40.1M | $40.3M | $37.4M |
| Deferred revenue (current) | $11.1M | $11.5M | $15.3M | $10.1M | $11.0M | $11.8M | $12.4M | $6.5M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | $319.1M | $318.7M | $354.6M | $109.7M | $36.2M | $36.1M | $36.1M | $227.9M |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.0M | $3.0M | $2.8M |
| Retained earnings | -$3.23B | -$3.21B | -$3.20B | -$3.18B | -$3.19B | -$3.19B | -$3.20B | -$3.21B |
| Accumulated other comprehensive income (loss) | -$19.0K | -$4.0K | $115.0K | $137.0K | $1.3M | $1.2M | $1.1M | $588.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$18.4M | -$5.4M | -$8.0M | $23.6M | $8.9M | -$6.4M | $22.6M | $9.3M |
| Investing cash flow | $17.9M | $18.7M | -$292.0M | -$25.1M | $6.3M | $6.0M | $48.2M | -$41.3M |
| Financing cash flow | $559.0K | -$35.4M | $247.4M | $71.8M | -$5.5M | $1.4M | -$86.9M | -$2.3M |
| Free cash flow | -$23.5M | -$7.2M | -$10.0M | $22.5M | $7.8M | -$6.7M | $19.7M | $7.9M |
| Capital expenditures | $5.1M | $1.9M | $2.0M | $1.1M | $1.1M | $330.0K | $2.9M | $1.4M |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $10.2M | $6.5M | $7.0M | $4.3M | $7.5M | $5.4M | $5.8M | $5.2M |
| Deferred income taxes | — | — | -$19.5M | — | — | — | $3.9M | — |
| Change in accounts receivable | $15.1M | -$10.3M | -$817.0K | -$9.8M | -$1.8M | $17.1M | -$6.4M | -$5.2M |
| Change in inventory | -$3.4M | $14.9M | -$797.0K | $1.8M | $4.2M | $1.5M | $3.2M | $2.2M |
| Change in accounts payable | -$5.1M | $7.1M | -$17.2M | -$3.0M | $5.2M | -$1.8M | $348.0K | -$3.1M |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Sales/maturities of investments | $23.0M | $30.9M | $71.5M | $42.0M | $51.4M | $50.4M | $58.1M | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
| Other financing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $349.0M | $285.5M | $199.0M | $99.8M | $75.4M |
| Operating income | $38.8M | $72.6M | $8.7M | -$64.1M | -$47.0M |
| Net income | $5.9M | $27.6M | -$11.9M | -$87.4M | -$80.9M |
| EPS (diluted) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 |
| EPS (basic) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 |
| Operating margin | $11 | $25 | $4 | -$64 | -$62 |
| Net margin | $2 | $10 | -$6 | -$88 | -$107 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $792.2M | $393.8M | $475.2M | $295.3M | $321.2M |
| Total liabilities | $843.2M | $472.7M | $721.4M | $545.8M | $530.5M |
| Stockholders' equity | -$51.0M | -$78.8M | -$246.2M | -$250.5M | -$209.3M |
| Total current assets | $291.6M | $268.3M | $373.4M | $234.9M | $219.5M |
| Total current liabilities | $171.0M | $81.8M | $104.1M | $67.3M | $48.3M |
| Cash & equivalents | $74.9M | $46.3M | $238.5M | $69.8M | $124.2M |
| Marketable securities (current) | $96.5M | $150.9M | $56.6M | $101.1M | $79.9M |
| Accounts receivable | $38.4M | $11.8M | $14.9M | $16.8M | $4.7M |
| Inventory | $35.3M | $27.9M | $28.5M | $21.8M | $7.2M |
| Marketable securities (non-current) | $5.0M | $5.5M | $7.2M | $2.0M | $56.6M |
| Property, plant & equipment | $82.4M | $85.4M | $84.2M | $45.1M | $36.6M |
| Goodwill | $67.6M | $1.9M | $1.9M | $2.4M | — |
| Intangible assets | $5.1M | $5.3M | $1.1M | $1.2M | — |
| Other non-current assets | $20.1M | $26.8M | $7.4M | $9.7M | $8.4M |
| Accounts payable | $9.0M | $6.8M | $9.6M | $11.1M | $7.0M |
| Accrued liabilities | $64.6M | $40.3M | $42.0M | $35.6M | $27.4M |
| Deferred revenue (current) | $15.3M | $12.4M | $9.1M | $1.7M | $827.0K |
| Long-term debt | $354.6M | $36.1M | $268.7M | $273.5M | $281.2M |
| Other non-current liabilities | — | — | — | — | $5.0M |
| Common stock & paid-in capital | $3.1M | $3.0M | $2.7M | $2.6M | $2.5M |
| Retained earnings | -$3.20B | -$3.20B | -$3.23B | -$3.22B | -$3.13B |
| Accumulated other comprehensive income (loss) | $115.0K | $1.1M | — | — | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $18.3M | $42.5M | $34.1M | -$80.7M | -$61.7M |
| Investing cash flow | -$304.8M | -$96.6M | -$2.0M | $4.9M | -$151.5M |
| Financing cash flow | $315.1M | -$137.3M | $136.6M | $21.4M | $270.3M |
| Free cash flow | $13.7M | $32.8M | -$8.3M | -$88.3M | -$73.2M |
| Capital expenditures | $4.6M | $9.7M | $42.4M | $7.6M | $11.5M |
| Depreciation & amortization | — | — | — | — | — |
| Share-based compensation | $24.2M | $21.4M | $17.6M | $13.4M | $12.2M |
| Deferred income taxes | -$19.5M | $3.9M | $6.8M | -$9.9M | -$19.6M |
| Change in accounts receivable | $4.8M | -$2.7M | -$2.3M | $11.8M | $776.0K |
| Change in inventory | $6.6M | $3.2M | $11.3M | $5.7M | $4.1M |
| Change in accounts payable | -$16.7M | -$2.8M | -$1.5M | $4.1M | $1.4M |
| Sales/maturities of investments | $215.3M | $58.1M | — | — | — |
| Debt issued | — | — | — | — | — |
| Tax withholding on stock comp | — | — | — | — | — |
| Other financing activities | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding MNKD as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-04-22 to 2026-09-25
Recent transactions
- Insiders have net sold 208,227 shares over the last 182 days, across 0 purchases and 7 sales.
- Most recent: Binder Steven B. (Reporting person) — Open market sale of 39,051 shares on 2026-09-25.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)208,227 sh(7 txns)
Net Shares-208,227
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Binder Steven B. | Reporting person | Open market sale | 2026-09-25 | 39,051 |
| Thomson David | EVP Genl Counsel & Secretary | Open market sale | 2026-07-17 | 24,109 |
| Prentiss Christopher B | Chief Financial Officer | Tax withholding | 2026-07-15 | 11,572 |
| Marasco Dominic | Pres, Endocrine Business Unit | Tax withholding | 2026-07-15 | 3,623 |
| Tross Stuart A | Chief People & Workpl Officer | Option exercise | 2026-07-15 | 93,790 |
| Castagna Michael | Chief Executive Officer | Option exercise | 2026-07-15 | 350,260 |
| Singh Sanjay R | EVP Technical Operations | Option exercise | 2026-07-15 | 70,550 |
| Consiglio Ronald J | Reporting person | Grant / award | 2026-05-20 | 10,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-25 | Binder Steven B. | Reporting person | Open market sale | 39,051 | $3.29 |
| 2026-09-10 | Binder Steven B. | Reporting person | Open market sale | 33,558 | $3.81 |
| 2026-08-07 | Binder Steven B. | Reporting person | Open market sale | 39,051 | $4.06 |
| 2026-07-17 | Thomson David | EVP Genl Counsel & Secretary | Open market sale | 24,109 | $4.05 |
| 2026-07-17 | Binder Steven B. | Reporting person | Open market sale | 52,485 | $4.06 |
| 2026-07-15 | Prentiss Christopher B | Chief Financial Officer | Tax withholding | 11,572 | $4.09 |
| 2026-07-15 | Prentiss Christopher B | Chief Financial Officer | Tax withholding | 10,675 | $4.09 |
| 2026-07-15 | Marasco Dominic | Pres, Endocrine Business Unit | Tax withholding | 3,623 | $4.09 |
| 2026-07-15 | Tross Stuart A | Chief People & Workpl Officer | Option exercise | 93,790 | $0.00 |
| 2026-07-15 | Tross Stuart A | Chief People & Workpl Officer | Tax withholding | 33,652 | $4.09 |
| 2026-07-15 | Tross Stuart A | Chief People & Workpl Officer | Tax withholding | 8,253 | $4.09 |
| 2026-07-15 | Tross Stuart A | Chief People & Workpl Officer | Tax withholding | 11,572 | $4.09 |
| 2026-07-15 | Tross Stuart A | Chief People & Workpl Officer | Tax withholding | 12,331 | $4.09 |
| 2026-07-15 | Castagna Michael | Chief Executive Officer | Option exercise | 350,260 | $0.00 |
| 2026-07-15 | Castagna Michael | Chief Executive Officer | Tax withholding | 192,819 | $4.09 |
| 2026-07-15 | Castagna Michael | Chief Executive Officer | Tax withholding | 47,481 | $4.09 |
| 2026-07-15 | Castagna Michael | Chief Executive Officer | Tax withholding | 63,996 | $4.09 |
| 2026-07-15 | Castagna Michael | Chief Executive Officer | Tax withholding | 58,904 | $4.09 |
| 2026-07-15 | Singh Sanjay R | EVP Technical Operations | Option exercise | 70,550 | $0.00 |
| 2026-07-15 | Singh Sanjay R | EVP Technical Operations | Tax withholding | 22,047 | $4.09 |
| 2026-07-15 | Singh Sanjay R | EVP Technical Operations | Tax withholding | 5,372 | $4.09 |
| 2026-07-15 | Singh Sanjay R | EVP Technical Operations | Tax withholding | 10,079 | $4.09 |
| 2026-07-15 | Singh Sanjay R | EVP Technical Operations | Tax withholding | 9,297 | $4.09 |
| 2026-07-15 | Thomson David | EVP Genl Counsel & Secretary | Option exercise | 93,790 | $0.00 |
| 2026-07-15 | Thomson David | EVP Genl Counsel & Secretary | Tax withholding | 51,632 | $4.09 |
| 2026-07-15 | Thomson David | EVP Genl Counsel & Secretary | Tax withholding | 12,662 | $4.09 |
| 2026-07-15 | Thomson David | EVP Genl Counsel & Secretary | Tax withholding | 17,754 | $4.09 |
| 2026-07-15 | Thomson David | EVP Genl Counsel & Secretary | Tax withholding | 16,378 | $4.09 |
| 2026-07-15 | Binder Steven B. | Reporting person | Option exercise | 93,790 | $0.00 |
| 2026-07-15 | Binder Steven B. | Reporting person | Tax withholding | 15,688 | $4.09 |
| 2026-07-15 | Binder Steven B. | Reporting person | Tax withholding | 4,073 | $4.09 |
| 2026-07-15 | Binder Steven B. | Reporting person | Tax withholding | 4,634 | $4.09 |
| 2026-05-20 | Consiglio Ronald J | Reporting person | Grant / award | 10,000 | $2.95 |
| 2026-05-20 | Tross Stuart A | Chief People & Workpl Officer | Grant / award | 33,898 | $2.95 |
| 2026-05-20 | Marasco Dominic | Pres, Endocrine Business Unit | Grant / award | 8,474 | $2.95 |
| 2026-05-12 | Binder Steven B. | Reporting person | Open market sale | 16,940 | $3.29 |
| 2026-05-12 | Thomson David | EVP Genl Counsel & Secretary | Open market sale | 3,033 | $3.29 |
| 2026-05-11 | Tross Stuart A | Chief People & Workpl Officer | Tax withholding | 8,073 | $3.52 |
| 2026-05-11 | Binder Steven B. | Reporting person | Tax withholding | 5,560 | $3.52 |
| 2026-05-11 | Castagna Michael | Chief Executive Officer | Tax withholding | 34,957 | $3.52 |
| 2026-05-11 | Thomson David | EVP Genl Counsel & Secretary | Tax withholding | 12,387 | $3.52 |
| 2026-04-22 | Prentiss Christopher B | Chief Financial Officer | Tax withholding | 12,267 | $2.74 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 03:36 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-28 | 4 | 2026-09-25 | View on SEC.gov → |
| 2026-09-14 | 4 | 2026-09-10 | View on SEC.gov → |
| 2026-08-21 | 8-K | 2026-08-21 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-07 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-24 | 8-K | 2026-07-23 | View on SEC.gov → |
| 2026-07-17 | 4 | 2026-07-15 | View on SEC.gov → |
| 2026-07-17 | 4 | 2026-07-15 | View on SEC.gov → |
| 2026-07-17 | 4 | 2026-07-15 | View on SEC.gov → |
| 2026-07-17 | 4 | 2026-07-15 | View on SEC.gov → |
| 2026-07-17 | 4 | 2026-07-15 | View on SEC.gov → |
Recent news
Headlines about MNKD (MannKind Corporation). Links open the publisher — we don’t host full articles.
-
MannKind Advances Inhaled IPF Drug to Global Phase 2, Eyes FUROSCIX Growth
Yahoo · 2026-10-20 -
Chardan starts coverage of MannKind stock with a USD 10.00 target
AD HOC NEWS · 2026-10-20 -
Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target
Benzinga · 2026-10-20 -
Learn Why The Bull Case For MannKind Stock Could Change Following Outpatient Diuretic Data
Yahoo · 2026-10-20 -
Chardan initiates MannKind stock coverage with buy rating on pipeline
Investing.com · 2026-10-19 -
MNKD Initiates Coverage On Chardan Capital -- Price Target Annou
GuruFocus · 2026-10-19 -
This MannKind Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Benzinga · 2026-10-19 -
Chardan Capital Initiates Coverage On MannKind with Buy Rating, Announces Price Target of $10
Benzinga · 2026-10-19
No headlines in this category right now — try “All”.